by Keith Koehler
For a while now, our clients have been telling us we should attend DCAT Week, and after waiting through the years of virtual and hybrid attendance, Excite Pharma has decided to go to New York later this month to spend time meeting with many within our industry to discuss a number of the big things that have been going on here over the past few months.
We are looking forward to telling everyone about the expansion in some of our capabilities that include injectables, spray products, a new nasal gel service, and a new eyedrop service. Now is the perfect time to sign a contract for your project. to be at the front of the line! Additionally, there usually is quite a bit of analytical work that needs to be done to prepare your project for success – all of which we offer at Excite.
Excite Pharma is both a CRO and CDMO. We develop and manufacture projects for our customers every day, just as we have for nearly 15 years now. We do all the chemistry from start to finish for the excipients, finished product, API, or whatever might be in your formulation. One of the things that makes us stand out is our focus on smaller batch manufacturing. Many of our competitors are looking for hundreds of thousands, or even millions of units, whereas we find many projects need only a few thousand units. We also have the ability to do hand fills and clinical supplies, which lead up to the commercial supplies, the small batches that a lot of the larger companies aren’t willing to do.
We are located in the Midwest, and our overhead and our operational costs are slightly less. So our pricing is a little better, while our quality remains top-notch and our team of experts are on-par with virtually anyone. We can do at the right combination of speed, quality and price, and – ultimately – our customers end up with a better product.
We have a number of locations in and around the Kansas City area, each of which has been tailored to specialize in a different type of science. Every facility specializes in a service we offer. So our nasal gel has its own new-finished and customized facility, the injectables are at their own facility, the spray line at its own facility, the eye drop line at its own facility. This translates to a decreased risk of cross-contamination and allows more specialty among work and training done by the experts reporting to those facilities.
If you would like to meet to discuss your analytical or manufacturing projects, fill out the form below and let us get you on our calendars while we’re there before our schedule fills up!
